Cited by 580Neurotransmitter Receptor Influence on BehaviorAttention Deficit Hyperactivity DisorderPharmacogenetics and Drug Metabolism

The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.

Is Methylphenidate Like Cocaine?: Studies on Their Pharmacokinetics and Distribution in the Human Brain

Volkow, Nora D.·1995·Archives of General Psychiatry

DOI 10.1001/archpsyc.1995.03950180042006

Open this paper in CoChat — free account

Abstract

BACKGROUND: The purposes of this study were to investigate the pharmacokinetics of methylphenidate hydrochloride (Ritalin) in the human brain, to compare them with those of cocaine, and to evaluate whether cocaine and methylphenidate compete for the same binding sites. METHODS: We used positron emission tomography to measure the temporal and spatial distribution of carbon 11 (11C)-labeled methylphenidate. These results were compared with those obtained previously for [11C]cocaine. Eight healthy male subjects, 20 to 51 years of age, were scanned with [11C]methylphenidate. Three were tested twice to assess test-retest variability, four were tested at baseline and after administration of methylphenidate, and one was tested with [11C]methylphenidate and [11C]cocaine. Two baboons were scanned to evaluate whether there was competition between cocaine and methylphenidate for the same binding sites in the brain. RESULTS: The uptake of [11C]methylphenidate in the brain was high (mean +/- SD, 7.5% +/- 1.5%), and the maximal concentration occurred in striatum. Pretreatment with methylphenidate decreased binding only in striatum (40%). Although the regional distribution of [11C]methylphenidate, was identical to that of [11C]cocaine and they competed with each other for the same binding sites, these two drugs differed markedly in their pharmacokinetics. Clearance of [11C]methylphenidate from striatum (90 minutes) was significantly slower than that of [11C]cocaine (20 minutes). For both drugs, their fast uptake in striatum paralleled the experience of the "high." For methylphenidate, the high decreased very rapidly despite significant binding of the drug in the brain. In contrast, for cocaine, the decline in the high paralleled its fast rate of clearance from the brain. CONCLUSION: We speculate that because the experience of the high is associated with the fast uptake of cocaine and methylphenidate in the brain, the slow clearance of methylphenidate from the brain may serve as a limiting factor in promoting its frequent self-administration.

Integrity signals

Registry

Crossref · 10.1001/archpsyc.1995.03950180042006

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cocaine Receptors on Dopamine Transporters Are Related to Self-Administration of Cocaine
Ritz, M. C., Lamb, R. J., Goldberg, S. R., & Kuhar, M. J. (1987) · Science · doi:10.1126/science.2820058 · Cited by 2,180
Cellular and molecular mechanisms of drug dependence
Koob, G. F., & Bloom, F. E. (1988) · Science · doi:10.1126/science.2903550 · Cited by 2,070
Graphical Analysis of Reversible Radioligand Binding from Time—Activity Measurements Applied to [ N - 11 C-Methyl]-(−)-Cocaine PET Studies in Human Subjects
Logan, J., Fowler, J. S., Volkow, N. D., Wolf, A. P., Dewey, S. L., Schlyer, D. J., MacGregor, R. R., HITZEMANN, R. J., Bendriem, B., Gatley, S. J., et al. (1990) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1990.127 · Cited by 1,481
Self-citation
The pharmacology of cocaine related to its abuse.
Johanson, C. E., & Fischman, M. W. (1989) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)00022-5 · Cited by 694
A REVIEW OF STIMULANT DRUG RESEARCH WITH HYPERACTIVE CHILDREN
Barkley, R. A. (1977) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.1977.tb00425.x · Cited by 542
Effects of cocaine and related drugs in nonhuman primates. III. Self-administration by squirrel monkeys.
Bergman, J., Madras, B. K., Johnson, S. E., & Spealman, R. D. (1989) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20689-9 · Cited by 394
Single photon emission computed tomographic imaging demonstrates loss of striatal dopamine transporters in Parkinson disease.
Innis, R. B., Seibyl, J. P., Scanley, B. E., Laruelle, M. A., Abi‐Dargham, A., Wallace, E. A., Baldwin, R. M., Zea‐Ponce, Y., Zoghbi, S. S., & Wang, S. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.24.11965 · Cited by 359
Cocaine Plasma Concentration: Relation to Physiological and Subjective Effects in Humans
Javaid, J. I., Fischman, M. W., Schuster, C. R., Dekirmenjian, H., & Davis, J. (1978) · Science · doi:10.1126/science.694530 · Cited by 336
FIXED‐INTERVAL SCHEDULE OF COCAINE REINFORCEMENT: EFFECT OF DOSE AND INFUSION DURATION1
Balster, R. L., & Schuster, C. R. (1973) · Journal of the Experimental Analysis of Behavior · doi:10.1901/jeab.1973.20-119 · Cited by 290
Mapping cocaine binding sites in human and baboon brain in vivo
Fowler, J. S., Volkow, N. D., Wolf, A. P., Dewey, S. L., Schlyer, D. J., MacGregor, R. R., HITZEMANN, R. J., Logan, J., Bendriem, B., Gatley, S. J., et al. (1989) · Synapse · doi:10.1002/syn.890040412 · Cited by 289
Self-citation

Show all 47 references

Sorted by citations

Items 101–200 of 580

Effects of methylphenidate, desipramine, and l-dopa on attention and inhibition in children with Attention Deficit Hyperactivity Disorder
Overtoom, C. C. E., Verbaten, M. N., Kemner, C., Kenemans, J. L., van Engeland, H., Buitelaar, J. K., van der Molen, M. W., van der Gugten, J., Westenberg, H. G. M., Maes, R. A. A., et al. (2003) · Behavioural Brain Research · doi:10.1016/s0166-4328(03)00097-4 · Cited by 138
ADHD, Substance Use Disorders, and Psychostimulant Treatment: Current Literature and Treatment Guidelines
Kollins, S. H. (2008) · Journal of Attention Disorders · doi:10.1177/1087054707311654 · Cited by 136
Dopamine-transporter occupancy after intravenous doses of cocaine and methylphenidate in mice and humans
Gatley, S. J., Volkow, N. D., Gifford, A. N., Fowler, J. S., Dewey, S. L., Ding, Y., & Logan, J. (1999) · Psychopharmacology · doi:10.1007/s002130051093 · Cited by 134
Self-citation
Pharmacology of methylphenidate, amphetamine enantiomers and pemoline in attention-deficit hyperactivity disorder
Patrick, K. S., & Markowitz, J. S. (1997) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/(sici)1099-1077(199711/12)12:6 · Cited by 132
Cerebrospinal Fluid Homovanillic Acid Predicts Behavioral Response to Stimulants in 45 Boys with Attention Deficit/Hyperactivity Disorder
Castellanos, F. X., Elia, J., Kruesi, M. J. P., Marsh, W., Gulotta, C. S., Potter, W. Z., Ritchie, G. F., Hamburger, S. D., & Rapoport, J. L. (1996) · Neuropsychopharmacology · doi:10.1016/0893-133x(95)00077-q · Cited by 129
Blockade of striatal dopamine transporters by intravenous methylphenidate is not sufficient to induce self-reports of “high”
Volkow, N. D., Wang, G.-J., Fowler, J. S., Gatley, S. J., Logan, J., Ding, Y.-S., Dewey, S. L., Hitzemann, R., Gifford, A. N., & Pappas, N. R. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37918-2 · Cited by 125
Self-citation
Methylphenidate elevates resting dopamine which lowers the impulse-triggered release of dopamine: a hypothesis
Seeman, P. M., & Madras, B. K. (2002) · Behavioural Brain Research · doi:10.1016/s0166-4328(01)00435-1 · Cited by 125
Pharmacokinetic and Pharmacodynamic Drug Interactions in the Treatment of Attention-Deficit Hyperactivity Disorder
Markowitz, J. S., & Patrick, K. S. (2001) · Clinical Pharmacokinetics · doi:10.2165/00003088-200140100-00004 · Cited by 123
Stimulant Actions in Rodents: Implications for Attention-Deficit/Hyperactivity Disorder Treatment and Potential Substance Abuse
Kuczenski, R. T., & Segal, D. S. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.12.036 · Cited by 121
Synthesis and Biological Evaluation of Bupropion Analogues as Potential Pharmacotherapies for Smoking Cessation
Carroll, F. I., Blough, B. E., Mascarella, S. W., Navarro, H. A., Eaton, J. B., Lukas, R. J., & Damaj, M. I. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm9017465 · Cited by 119
Methylphenidate-induced dendritic spine formation and ΔFosB expression in nucleus accumbens
Kim, Y. D., Teylan, M., Baron, M. L., Sands, A., Nairn, A. C., & Greengard, P. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813179106 · Cited by 121
Mixing pleasures: Review of the effects of drugs on sex behavior in humans and animal models
Frohmader, K. S., Pitchers, K. K., Balfour, M. E., & Coolen, L. M. (2009) · Hormones and Behavior · doi:10.1016/j.yhbeh.2009.11.009 · Cited by 121
Dopamine Receptor 4 (DRD4) 7-Repeat Allele Predicts Methylphenidate Dose Response in Children with Attention Deficit Hyperactivity Disorder: A Pharmacogenetic Study
Hamarman, S., Fossella, J., Ülger, C., Brimacombe, M. B., & Dermody, J. J. (2004) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2004.14.564 · Cited by 118
Comparison of acute behavioral effects of sustained-release and immediate-release methylphenidate.
Kollins, S. H., Rush, C. R., Pazzaglia, P. J., & Ali, J. A. (1998) · Experimental and Clinical Psychopharmacology · doi:10.1037//1064-1297.6.4.367 · Cited by 117
Delusional parasitosis and the dopamine transporter. A new insight of etiology?
Huber, M. K., Kirchler, E., Kärner, M., & Pycha, R. (2006) · Medical Hypotheses · doi:10.1016/j.mehy.2006.07.061 · Cited by 114
Comparing the abuse potential of methylphenidate versus other stimulants: a review of available evidence and relevance to the ADHD patient.
Kollins, S. H. (2003) · PubMed · Cited by 111
Timing, Space and ADHD: The Dopamine Theory Revisited
Lévy, F., & Swanson, J. M. (2001) · Australian & New Zealand Journal of Psychiatry · doi:10.1046/j.1440-1614.2001.00923.x · Cited by 115
A Positron Emission Tomography Study Of Methylphenidate in Adults with ADHD: Alterations in Resting Blood Flow and Predicting Treatment Response
Schweitzer, J. B., Lee, D. O., Hanford, R. B., Tagamets, M. A., Hoffman, J. M., Grafton, S. T., & Kilts, C. D. (2002) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300110 · Cited by 108
Dopamine agonists for the treatment of cocaine dependence
Minozzi, S., Amato, L., Pani, P. P., Solimini, R., Vecchi, S., Crescenzo, F. D., Zuccaro, P., & Davoli, M. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003352.pub4 · Cited by 108
Repeated methylphenidate treatment in adolescent rats alters gene regulation in the striatum
Brandon, C. L., & Steiner, H. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02892.x · Cited by 105
Cardiovascular effects of methylphenidate in humans are associated with increases of dopamine in brain and of epinephrine in plasma
Volkow, N., Wang, G.-J., Fowler, J., Molina, P., Logan, J., Gatley, S., Gifford, A., Ding, Y.-S., Wong, C. T., Pappas, N., et al. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1340-7 · Cited by 104
Self-citation
Substance Abuse in Patients with Attention-Deficit Hyperactivity Disorder: Therapeutic Implications
Schubiner, H. (2005) · CNS Drugs · doi:10.2165/00023210-200519080-00001 · Cited by 104
Identifying Medication Targets for Psychostimulant Addiction: Unraveling the Dopamine D3 Receptor Hypothesis
Keck, T. M., John, W. S., Czoty, P. W., Nader, M. A., & Newman, A. H. (2015) · Journal of Medicinal Chemistry · doi:10.1021/jm501512b · Cited by 101
Effects of chronic oral methylphenidate on cocaine self-administration and striatal dopamine D2 receptors in rodents
Thanos, P. K., Michaelides, M., Benveniste, H., Wang, G. J., & Volkow, N. D. (2007) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2007.05.020 · Cited by 100
Self-citation
An update on the clinical pharmacology of methylphenidate: therapeutic efficacy, abuse potential and future considerations
Shellenberg, T., Stoops, W. W., Lile, J. A., & Rush, C. R. (2020) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2020.1796636 · Cited by 98
Fast uptake and long-lasting binding of methamphetamine in the human brain: Comparison with cocaine
Fowler, J. S., Volkow, N. D., Logan, J., Alexoff, D. L., Telang, F., Wang, G., Wong, C., Ma, Y., Kriplani, A., Pradhan, K., et al. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2008.07.020 · Cited by 98
Self-citation
A qualitative review of issues arising in the use of psychostimulant medications in patients with ADHD and co‑morbid substance use disorders
Kollins, S. H. (2008) · Current Medical Research and Opinion · doi:10.1185/030079908x280707 · Cited by 97
Anorexia nervosa: Friend or foe?
Serpell, L., Treasure, J. L., Teasdale, J., & Sullivan, V. (1999) · International Journal of Eating Disorders · doi:10.1002/(sici)1098-108x(199903)25:2 · Cited by 410
Thalamo-cortical dysfunction in cocaine abusers: Implications in attention and perception
Tomasi, D. G., Goldstein, R. Z., Telang, F., Maloney, T., Alia‐Klein, N., Caparelli, E. C., & Volkow, N. D. (2007) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2007.03.002 · Cited by 100
Self-citation
Electroencephalographic biofeedback (neurotherapy) as a treatment for attention deficit hyperactivity disorder: rationale and empirical foundation
Monastra, V. J. (2005) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2004.07.004 · Cited by 96
Effects of expectation on the brain metabolic responses to methylphenidate and to its placebo in non-drug abusing subjects
Volkow, N., Wang, G.-J., Ma, Y.-M., Fowler, J., Wong, C. T., Jayne, M., Telang, F., & Swanson, J. (2006) · NeuroImage · doi:10.1016/j.neuroimage.2006.04.192 · Cited by 100
Self-citation
Enantioselective Synthesis of d -threo-Methylphenidate
Axten, J. M., Ivy, R., Krim, L., & Winkler, J. D. (1999) · Journal of the American Chemical Society · doi:10.1021/ja991466o · Cited by 93
Differential distribution, affinity and plasticity of dopamine D-1 and D-2 receptors in the target sites of the mesolimbic system in an animal model of ADHD
Carey, M. P., Diewald, L., Esposito, F., Pellicano, M. P., Carnevale, U. A. G., Sergeant, J. A., Papa, M., & Sadile, A. G. (1998) · Behavioural Brain Research · doi:10.1016/s0166-4328(97)00178-2 · Cited by 94
A linear model for estimation of neurotransmitter response profiles from dynamic PET data
Normandin, M. D., Schiffer, W. K., & Morris, E. D. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2011.07.002 · Cited by 94
Smoking produces rapid rise of [11C]nicotine in human brain
Berridge, M. S., Apana, S. M., Nagano, K. K., Berridge, C. E., Leisure, G. P., & Boswell, M. V. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1809-8 · Cited by 90
Evaluation of a new norepinephrine transporter PET ligand in baboons, both in brain and peripheral organs
Ding, Y., Lin, K., Garza, V., Carter, P., Alexoff, D., Logan, J., Shea, C. E., Xu, Y., & King, P. T. (2003) · Synapse · doi:10.1002/syn.10281 · Cited by 90
Slow-Onset, Long-Duration 3-(3‘,4‘-Dichlorophenyl)-1-indanamine Monoamine Reuptake Blockers as Potential Medications To Treat Cocaine Abuse
Froimowitz, M., Wu, K.-M., Moussa, A. M., Haidar, R. M., Jurayj, J., George, C. F., & Gardner, E. L. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm000201d · Cited by 88
Striatal lesions in delusional parasitosis revealed by magnetic resonance imaging
Huber, M. K., Kärner, M., Kirchler, E., Lepping, P., & Freudenmann, R. W. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.09.014 · Cited by 88
Patterns and predictors of medication compliance, diversion, and misuse in adult prescribed methylphenidate users
Darredeau, C., Barrett, S. P., Jardin, B. F., & Pihl, R. O. (2007) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.883 · Cited by 86
Recent Advances in Imaging of Dopaminergic Neurons for Evaluation of Neuropsychiatric Disorders
Shen, L., Liao, M.-H., & Tseng, Y.-C. (2012) · BioMed Research International · doi:10.1155/2012/259349 · Cited by 95
Metabolism, Distribution and Elimination of Lisdexamfetamine Dimesylate
Krishnan, S. M., Pennick, M., & Stark, J. G. (2008) · Clinical Drug Investigation · doi:10.2165/0044011-200828120-00002 · Cited by 85
On the nature of extraversion: variation in conditioned contextual activation of dopamine-facilitated affective, cognitive, and motor processes
Depue, R. A., & Fu, Y. (2013) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2013.00288 · Cited by 90
Disagreements with implications: diverging discourses on the ethics of non-medical use of methylphenidate for performance enhancement
Forlini, C., & Racine, É. (2009) · BMC Medical Ethics · doi:10.1186/1472-6939-10-9 · Cited by 83
Poison Centers’ Experience With Methylphenidate Abuse in Pre-Teens and Adolescents
Klein‐Schwartz, W., & McGrath, J. C. (2003) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200303000-00008 · Cited by 82
Pharmacokinetic Considerations in the Treatment of Attention-Deficit Hyperactivity Disorder with Methylphenidate
Wolraich, M. L., & Doffing, M. (2004) · CNS Drugs · doi:10.2165/00023210-200418040-00004 · Cited by 86
Behavioral pharmacological similarities between methylphenidate and cocaine in cocaine abusers.
Rush, C. R., & Baker, R. W. (2001) · Experimental and Clinical Psychopharmacology · doi:10.1037/1064-1297.9.1.59 · Cited by 82
Attention deficit/hyperactivity disorder (ADHD) in children: rationale for its integrative management.
Kidd, P. M. (2000) · PubMed · Cited by 82
Methylphenidate for attention-deficit/hyperactivity disorder in adults: a narrative review
Jaeschke, R. R., Sujkowska, E., & Sowa-Kućma, M. (2021) · Psychopharmacology · doi:10.1007/s00213-021-05946-0 · Cited by 106
Chronic Cocaine Dampens Dopamine Signaling during Cocaine Intoxication and Unbalances D1over D2Receptor Signaling
Park, K., Volkow, N. D., Pan, Y., & Du, C. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.1935-13.2013 · Cited by 83
Self-citation
Ethylphenidate Formation in Human Subjects after the Administration of a Single Dose of Methylphenidate and Ethanol
Markowitz, J. S., DeVane, C. L., Boulton, D. W., Nahas, Z. H., Risch, S. C., Diamond, F., & Patrick, K. S. (2000) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15139-2 · Cited by 80
Psychopharmacology: concepts and opinions about the use of stimulant medications
Swanson, J. M., & Volkow, N. D. (2009) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2008.02062.x · Cited by 78
Self-citation
Bupropion for attention deficit hyperactivity disorder (ADHD) in adults.
Verbeeck, W., Bekkering, G., den Noortgate, W. V., & Kramers, C. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009504.pub2 · Cited by 73
METHYLPHENIDATE (RITALIN): BEHAVIORAL STUDIES IN THE RAT
Askenasy, E. P., Taber, K. H., Yang, P. B., & Dafny, N. (2007) · International Journal of Neuroscience · doi:10.1080/00207450600910176 · Cited by 78
[11]Cocaine: PET studies of cocaine pharmacokinetics, dopamine transporter availability and dopamine transporter occupancy
Fowler, J. S., Volkow, N. D., Wang, G., Gatley, S. J., & Logan, J. (2001) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(01)00211-6 · Cited by 77
Self-citation
Increased vulnerability to cocaine in mice lacking dopamine D 3 receptors
Song, R., Zhang, H., Li, X., Bi, G., Gardner, E. L., & Xi, Z. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1205297109 · Cited by 82
Restoration of Disturbed Intracortical Motor Inhibition and Facilitation in Attention Deficit Hyperactivity Disorder Children by Methylphenidate
Buchmann, J. A., Gierow, W., Simone, W., Hoeppner, J., Klauer, T., Benecke, R., Haessler, F., & Wolters, A. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.05.010 · Cited by 77
Do Formulation Differences Alter Abuse Liability of Methylphenidate?: A Placebo-Controlled, Randomized, Double-Blind, Crossover Study in Recreational Drug Users
Parasrampuria, D., Schoedel, K., Schuller, R., Silber, S., Ciccone, P., Gu, J., & Sellers, E. (2007) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181515205 · Cited by 65
“Wanting,” “liking,” and their relation to consciousness.
Anselme, P., & Robinson, M. J. F. (2015) · Journal of Experimental Psychology Animal Learning and Cognition · doi:10.1037/xan0000090 · Cited by 82
Role of executive function in ADHD.
Swanson, J. M. (2003) · PubMed · Cited by 75
Effects of repeated methylphenidate treatment in the young rat: Sensitization of both locomotor activity and stereotyped sniffing.
McDougall, S. A., Collins, R. L., Karper, P. E., Watson, J. B., & Crawford, C. A. (1999) · Experimental and Clinical Psychopharmacology · doi:10.1037/1064-1297.7.3.208 · Cited by 73
Pretreatment with methylphenidate sensitizes rats to the reinforcing effects of cocaine
Schenk, S., & Izenwasser, S. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(02)00735-9 · Cited by 72
Sleepiness and the reinforcing and subjective effects of methylphenidate.
Roehrs, T., Papineau, K. L., Rosenthal, L. D., & Roth, T. G. (1999) · Experimental and Clinical Psychopharmacology · doi:10.1037//1064-1297.7.2.145 · Cited by 72
New Formulations of Stimulants for Attention-Deficit Hyperactivity Disorder
Connor, D. F., & Steingard, R. J. (2004) · CNS Drugs · doi:10.2165/00023210-200418140-00005 · Cited by 71
Attention-Deficit/Hyperactivity Disorder and Early-Onset Substance Use Disorders
Wilson, J. J., & Levin, F. R. (2005) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2005.15.751 · Cited by 71
Stimulant medications: how to minimize their reinforcing effects?
VOLKOW, N. D. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.3.359 · Cited by 70
Self-citation
Progress in agonist therapy for substance use disorders: Lessons learned from methadone and buprenorphine
Jordan, C. J., Cao, J., Newman, A. H., & Xi, Z. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.04.015 · Cited by 70
Hypothesis-Driven Medication Discovery for the Treatment of Psychostimulant Addiction
Xi, Z., & Gardner, E. L. (2008) · Current Drug Abuse Reviews · doi:10.2174/1874473710801030303 · Cited by 70
A science of meaning: Can behaviorism bring meaning to psychological science?
DeGrandpre, R. J. (2000) · American Psychologist · doi:10.1037/0003-066x.55.7.721 · Cited by 74
Chronic methylphenidate alters locomotor activity and dopamine transporters differently from cocaine
Izenwasser, S., Coy, A. E., Ladenheim, B., Loeloff, R. J., Cadet, J. L., & French, D. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00274-5 · Cited by 69
ntPET: A New Application of PET Imaging for Characterizing the Kinetics of Endogenous Neurotransmitter Release
Morris, E. D., Yoder, K. K., Wang, C., Normandin, M. D., Zheng, Q., Mock, B. H., Raymond, F. M., & Froehlich, J. C. (2005) · Molecular Imaging · doi:10.2310/7290.2005.05130 · Cited by 69
Non-selective attention in a rat model of hyperactivity and attention deficit: subchronic methylphenydate and nitric oxide synthesis inhibitor treatment
Aspide, R., Fresiello, A., de Filippis, G., Carnevale, U. A. G., & Sadile, A. G. (2000) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(99)00045-7 · Cited by 69
Use of methylphenidate in patients with cancer
Sood, A., Barton, D. L., & Loprinzi, C. L. (2006) · American Journal of Hospice and Palliative Medicine® · doi:10.1177/104990910602300106 · Cited by 68
The Abuse Liability and Therapeutic Potential of Drugs Evaluated for Cocaine Addiction as Predicted by Animal Models
Lile, J. A., & Nader, M. A. (2003) · Current Neuropharmacology · doi:10.2174/1570159033360566 · Cited by 66
Occupancy of dopamine D 2 receptors in the mouse brain measured using ultra-high-resolution single-photon emission tomography and [ 123 I]IBF
Acton, P. D., Hou, C., Kung, M., Plöessl, K., Keeney, C., & Kung, H. F. (2002) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-002-0903-5 · Cited by 66
Bupropion and Bupropion Analogs as Treatments for CNS Disorders
Carroll, F. I., Blough, B. E., Mascarella, S. W., Navarro, H. A., Lukas, R. J., & Damaj, M. I. (2014) · Advances in pharmacology · doi:10.1016/b978-0-12-420118-7.00005-6 · Cited by 67
Chronic pretreatment with methylphenidate induces cross-sensitization with amphetamine
Yang, P. B., Swann, A. C., & Dafny, N. (2003) · Life Sciences · doi:10.1016/s0024-3205(03)00673-8 · Cited by 65
Abuse Liability of Medications Used to Treat Attention‐Deficit/Hyperactivity Disorder (ADHD)
Kollins, S. H. (2007) · American Journal on Addictions · doi:10.1080/10550490601082775 · Cited by 65
Cannabis Abusers Show Hypofrontality and Blunted Brain Responses to a Stimulant Challenge in Females but not in Males
Wiers, C. E., Kojori, E. S., Wong, C., Abi‐Dargham, A., Demiral, Ş. B., Tomasi, D. G., Wang, G., & Volkow, N. D. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.67 · Cited by 64
Self-citation
Dopamine transporter as target for drug development of cocaine dependence medications
Dutta, A. K., Zhang, S., Kolhatkar, R. B., & Reith, M. E. A. (2003) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2003.08.060 · Cited by 65
Methylphenidate enhances extinction of contextual fearPreprint
Abraham, A. D., Cunningham, C. L., & Lattal, K. M. (2012) · Learning & Memory · doi:10.1101/lm.024752.111 · Cited by 66
Pharmacokinetics of Methylphenidate in Preschoolers with Attention-Deficit/Hyperactivity Disorder
Wigal, S. B., Gupta, S., Greenhill, L. L., Posner, K., Lerner, M., Steinhoff, K. W., Wigal, T. L., Kapelinski, A., Martinez, J. I., Modi, N. B., et al. (2007) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2007.0043 · Cited by 64
INTRANASAL ABUSE OF PRESCRIBED METHYLPHENIDATE
Garland, E. (1998) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199806000-00006 · Cited by 64
Methylphenidate and substance abuse: A review of pharmacology, animal, and clinical studies
Huss, M., & Lehmkuhl, U. (2002) · Journal of Attention Disorders · doi:10.1177/070674370200601s09 · Cited by 65
Methylphenidate and Dextroamphetamine Abuse in Substance‐Abusing Adolescents
Williams, R. J., Goodale, L. A., Shay‐Fiddler, M. A., Gloster, S. P., & Chang, S. Y. (2004) · American Journal on Addictions · doi:10.1080/10550490490483053 · Cited by 63
Polymorphisms of the Dopamine Transporter Gene
Roman, T., Rohde, L. A., & Hutz, M. H. (2004) · American Journal of PharmacoGenomics · doi:10.2165/00129785-200404020-00003 · Cited by 61
Dissociation in response to methylphenidate on response variability in a group of medication naïve children with ADHD
Johnson, K. A., Barry, E., Bellgrove, M. A., Cox, M., Kelly, S. P., Dáibhis, A., Daly, M., Keavey, M., Watchorn, A., Fitzgerald, M., et al. (2008) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2008.01.002 · Cited by 62
Dasotraline for the Treatment of Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Trial in Adults
Koblan, K., Hopkins, S., Sarma, K., Jin, F., Goldman, R., Kollins, S., & Loebel, A. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.124 · Cited by 60
Noninvasive Brain Stimulation in Pediatric Attention-Deficit Hyperactivity Disorder (ADHD)
Rubio, B., Boes, A. D., Laganiere, S. E., Rotenberg, A., Jeurissen, D., & Pascual‐Leone, Á. (2015) · Journal of Child Neurology · doi:10.1177/0883073815615672 · Cited by 64
Agonist Replacement for Stimulant Dependence: A Review of Clinical Research
Stoops, W. W., & Rush, C. (2013) · Current pharmaceutical design · doi:10.2174/138161281940131209142843 · Cited by 65
Positron emission tomography neuroimaging for a better understanding of the biology of ADHD
Zimmer, L. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.08.001 · Cited by 63
Electroencephalographic Biofeedback in the Treatment of Attention-Deficit/Hyperactivity Disorder
Monastra, V. J., Lynn, S. J., Linden, M., Lubar, J. F., Gruzelier, J. H., & Vaque, T. J. L. (2006) · Journal of Neurotherapy · doi:10.1300/j184v09n04_02 · Cited by 60
Effect of methylphenidate on dopamine/DARPP signalling in adult, but not young, mice
Fukui, R., Svenningsson, P., Matsuishi, T., Higashi, H., Nairn, A. C., Greengard, P., & Nishi, A. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02101.x · Cited by 58
The use of a laboratory school protocol to evaluate concepts about efficacy and side effects of new formulations of stimulant medications
Swanson, J. M., Lerner, M., Wigal, T. L., Steinhoff, K. W., Greenhill, L. L., Posner, K., Freid, J., & Wigal, S. B. (2002) · Journal of Attention Disorders · doi:10.1177/070674370200601s10 · Cited by 57
Temporal relationships between the pharmacokinetics of methylphenidate in the human brain and its behavioral and cardiovascular effects
Volkow, N. D., Wang, G., Gatley, S. J., Fowler, J. S., Ding, Y., Logan, J., Volkow, N. D., Hitzemann, R., ANGRIST, B. M., & Lieberman, J. A. (1996) · Psychopharmacology · doi:10.1007/bf02246277 · Cited by 56
Self-citation
Pleasure and discipline in the uses of Ritalin
Keane, H. (2008) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2007.08.002 · Cited by 57
Guanfacine Extended Release: A New Pharmacological Treatment Option in Europe
Huß, M., Chen, W., & Ludolph, A. G. (2015) · Clinical Drug Investigation · doi:10.1007/s40261-015-0336-0 · Cited by 60
8.3 Imaging Dopamine’s Role in Drug Abuse and Addiction
Volkow, N. D., Fowler, J. S., Wang, G., Telang, F., & Baler, R. (2009) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195373035.003.0028 · Cited by 58
Self-citation
From Clinical Application to Cognitive Enhancement: The Example of Methylphenidate
Busardò, F. P., Kyriakou, C., Cipolloni, L., Zaami, S., & Frati, P. (2016) · Current Neuropharmacology · doi:10.2174/1570159x13666150407225902 · Cited by 59
The Role of Methylphenidate in Psychiatry
Wender, P. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950180015003 · Cited by 55
Drosophila as a Model System for Neurotransmitter Measurements
Shin, M., Copeland, J. M., & Venton, B. J. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00456 · Cited by 54

Authors: Volkow, N. D.
Affiliations: Brookhaven National Laboratory (US)
Corresponding author: Volkow, Nora D.
ORCID: Volkow, Nora D.
Venue: Archives of General Psychiatry
Publisher: American Medical Association (AMA)
Published: 1995-06-01
Volume: 52
Issue: 6
Pages: 456
ISSN: 0003-990X (ISSN-L)
DOI: 10.1001/archpsyc.1995.03950180042006
OpenAlex: W2116795024
Cited by: 575
References: 47
Citations by year: 2026: 2 · 2025: 5 · 2024: 9 · 2023: 12 · 2022: 8 · 2021: 14 · 2020: 13 · 2019: 10 · 2018: 9 · 2017: 9 · 2016: 16 · 2015: 20 · 2014: 21 · 2013: 22 · 2012: 33
FWCI: 5.34
Type: journal article
Language: en
Open access: closed
Locations: Archives of General Psychiatry (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (5p01ns015638-15)
National Institute on Drug Abuse (5RO1-DA06891, R01DA006891)
National Institute of Neurological Disorders and Stroke (NS15638)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
Keywords: methylphenidate, cocaine, brain pharmacokinetics, striatum, binding site competition, drug clearance, self-administration, positron emission tomography
MeSH terms: Adult, Animals, Brain, Carbon Radioisotopes, Cerebellum, Cocaine, Corpus Striatum, Half-Life, Humans, Male, Methylphenidate, Middle Aged, Papio, Self Medication, Time Factors, Tissue Distribution, Tomography, Emission-Computed, Substance-Related Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Is Methylphenidate Like Cocaine?: Studies on Their Pharmacokinetics and Distribution in the Human Brain

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks